pegylated liposomal doxorubicin hydrochloride [clinicaltrials_resource:66e9896ac7b4d14689df1664b2dcce6e]
intervention [clinicaltrials_vocabulary:intervention]
pegylated liposomal doxorubicin hydrochloride [clinicaltrials_resource:66e9896ac7b4d14689df1664b2dcce6e]
Bio2RDF identifier
66e9896ac7b4d14689df1664b2dcce6e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:66e9896ac7b4d14689df1664b2dcce6e
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Liposomal doxorubicin at a fix ...... on day 1 of each 28 day cycle
intervention name [clinicaltrials_vocabulary:intervention-name]
pegylated liposomal doxorubicin hydrochloride
other name [clinicaltrials_vocabulary:other-name]
identifier
clinicaltrials_resource:66e9896ac7b4d14689df1664b2dcce6e
title
pegylated liposomal doxorubicin hydrochloride
@en
type
label
pegylated liposomal doxorubici ...... 9896ac7b4d14689df1664b2dcce6e]
@en